Table 4.
Predictor |
Global cognition decline
|
||
---|---|---|---|
Total variance | Reduction | % Total variance explained | |
Reference model | 0.0094 | – | – |
Separate models | |||
Global Alzheimer’s disease pathology | 0.0069 | 0.0025 | 27% |
Amyloid-β | 0.0082 | 0.0012 | 13% |
PHFtau tangles | 0.0061 | 0.0033 | 35% |
Neocortical Lewy bodies | 0.0090 | 0.0004 | 4% |
LATE-NC (4 stages) | 0.0088 | 0.0006 | 7% |
Hippocampal sclerosis | 0.0091 | 0.0003 | 3% |
Gross infarcts, chronic | 0.0093 | 0.0001 | 1% |
Microscopic infarcts, chronic | 0.0094 | 0.0000 | 0% |
Atherosclerosis | 0.0092 | 0.0002 | 3% |
Arteriolosclerosis | 0.0093 | 0.0001 | 2% |
Cerebral amyloid angiopathy | 0.0090 | 0.0004 | 5% |
Multivariate models | |||
Six pathologiesa | 0.0057 | 0.0037 | 40% |
All 11 pathologies | 0.0054 | 0.0040 | 43% |
Includes global‘ Alzheimer’s disease pathology, amyloid-β, PHFtau tangles, neocortical Lewy bodies, gross infarcts, and microscopic infarcts.